BML-259
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Product Specifications
CAS Number
267654-00-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
260.36
Molecular Formula
C14H16N2OS
Notes
Research use only, not for human use.
Receptor
Antifungal|Antiviral
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1283202-01 0.5 mg (E-Coli)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details 
MBS1283202-02 0.05 mg (Baculovirus)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details MBS1283202-03 0.5 mg (Yeast)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details MBS1283202-04 0.05 mg (Mammalian-Cell)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details MBS1283202-05 1 mg (E-Coli)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details MBS1283202-06 0.1 mg (Baculovirus)
Recombinant Takifugu rubripes Mast/stem cell growth factor receptor Kit (kit), partial
Ask
View Details